Dr. Amin A. Yehya, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
600 Gresham Dr
Norfolk, VA 23507
Who else practices at this address →
Norfolk city is a federal dental shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 653
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
VA license 0101266385 · GA license 072178 -
Cardiovascular Disease Physician
GA license 072178 · VA license 0101266385
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Sentara Norfolk General Hospital Norfolk, VA
- Sentara Leigh Hospital Norfolk, VA
- Sentara Virginia Beach General Hospital Virginia Beach, VA
- Sentara Careplex Hospital Hampton, VA
- Sentara Williamsburg Regional Medical Center Williamsburg, VA
Medical groups
- Sentara Medical Group (1,408 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 653
- Services billed
- 1,698
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 454 | 439 |
| Established patient office or other outpatient visit, 30-39 minutes | 415 | 193 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 334 | 304 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 251 | 96 |
| Established patient office or other outpatient visit, 40-54 minutes | 176 | 104 |
| Evaluation of lower heart chamber assist device | 96 | 18 |
| Ultrasound of heart, follow-up | 67 | 62 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | 58 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 51 | 47 |
| Remote monitoring of pulmonary artery pressure sensor, up to 30 days | 36 | 29 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Entresto (sacubitril/valsartan) Other prescribers in Norfolk, VA | 493 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Norfolk, VA | 428 |
| Spironolactone Other prescribers in Norfolk, VA | 426 |
| Furosemide Other prescribers in Norfolk, VA | 361 |
| Carvedilol Other prescribers in Norfolk, VA | 332 |
| Metoprolol Succinate Other prescribers in Norfolk, VA | 264 |
| Atorvastatin Calcium Other prescribers in Norfolk, VA | 159 |
| Bumetanide Other prescribers in Norfolk, VA | 134 |
| Jardiance (empagliflozin) Other prescribers in Norfolk, VA | 120 |
| Losartan Potassium Other prescribers in Norfolk, VA | 98 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 135 payments worth $140,000 in total to this clinician.
| Bayer HealthCare Pharmaceuticals Inc. | $52,229 |
|---|---|
| Scpharmaceuticals Inc. | $27,249 |
| Kestra Medical Technology Services, Inc. | $21,634 |
| Cvrx, Inc. | $11,222 |
| Bridgebio Pharma, Inc. | $10,598 |
| Nuwellis, Inc. | $9,512 |
| AstraZeneca Pharmaceuticals LP | $6,419 |
| Merck Sharp & Dohme LLC | $896 |
| Compensation for services other than consulting (speaking, faculty) | $52,326 |
|---|---|
| Consulting Fee | $46,175 |
| Honoraria | $25,600 |
| Travel and Lodging | $10,874 |
| Food and Beverage | $4,633 |
| Education | $392 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. Jun 13, 2025 | Consulting Fee Assure WCD · Cardiology/Vascular Diseases | $18,000 |
| Scpharmaceuticals Inc. Dec 5, 2025 | Honoraria FUROSCIX · Cardiology | $8,000 |
| Cvrx, Inc. Nov 12, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $7,750 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 16, 2025 | Consulting Fee Kerendia · Cardio-Renal | $7,592 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 14, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $6,409 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $5,278 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 1, 2025 | Consulting Fee | $5,061 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,901 |
| Scpharmaceuticals Inc. Mar 7, 2025 | Honoraria FUROSCIX · Cardiology | $4,800 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,147 |
All 73 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. Dec 11, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to New Orleans, LA · in-kind | $280 |
| Scpharmaceuticals Inc. Dec 5, 2025 | Honoraria FUROSCIX · Cardiology | $8,000 |
| Bayer HealthCare Pharmaceuticals Inc. Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,147 |
| Scpharmaceuticals Inc. Dec 2, 2025 | Honoraria FUROSCIX · Cardiology | $3,200 |
| Scpharmaceuticals Inc. Dec 2, 2025 | Travel and Lodging FUROSCIX · Cardiology · travel to NEWPORT NEWS, VA | $35.07 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 24, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Elizabeth City, NC · in-kind | $781 |
| Nuwellis, Inc. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) Aquadex Smartflow Console · Cardiology | $3,120 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 21, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to New Orleans, LA · in-kind | $174 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 21, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to New Orleans, LA · in-kind | $50.00 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 14, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $6,409 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,901 |
| Cvrx, Inc. Nov 12, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $7,750 |
| Cvrx, Inc. Nov 12, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Minneapolis, MN | $181 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 8, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Halifax, VA, VA · in-kind | $1,555 |
| Scpharmaceuticals Inc. Nov 3, 2025 | Honoraria FUROSCIX · Cardiology | $3,200 |
| Scpharmaceuticals Inc. Nov 3, 2025 | Travel and Lodging FUROSCIX · Cardiology · travel to SUFFOLK, VA | $37.71 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,147 |
| Bridgebio Pharma, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Attruby · Cardiomyopathy | $2,790 |
| Bridgebio Pharma, Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Attruby · Cardiomyopathy | $2,790 |
| Bridgebio Pharma, Inc. Oct 30, 2025 | Travel and Lodging Attruby · Cardiomyopathy · travel to Richmond, VA | $298 |
| Bridgebio Pharma, Inc. Oct 30, 2025 | Travel and Lodging Attruby · Cardiomyopathy · travel to Richmond, VA | $125 |
| Bridgebio Pharma, Inc. Oct 30, 2025 | Travel and Lodging Attruby · Cardiomyopathy · travel to Richmond, VA | $5.00 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 29, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Virginia Beach, VA · in-kind | $11.97 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Richmond, VA · in-kind | $149 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Richmond, VA · in-kind | $8.00 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,147 |
| Cvrx, Inc. Oct 13, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Minneapolis, MN | $353 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 10, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $179 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $5,278 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Whippany, NJ · in-kind | $529 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Whippany, NJ · in-kind | $50.00 |
| Nuwellis, Inc. Oct 4, 2025 | Education Aquadex Smartflow Console · Cardiology | $255 |
| Nuwellis, Inc. Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) Aquadex Smartflow Console · Cardiology | $2,800 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 1, 2025 | Consulting Fee | $5,061 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $377 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 6, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Whippany, NJ · in-kind | $541 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 4, 2025 | Consulting Fee | $723 |
| Cvrx, Inc. Sep 3, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $200 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 22, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $754 |
| Scpharmaceuticals Inc. Aug 18, 2025 | Honoraria FUROSCIX · Cardiology | $3,200 |
| Scpharmaceuticals Inc. Aug 18, 2025 | Travel and Lodging FUROSCIX · Cardiology · travel to CHESAPEAKE, VA | $16.59 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $275 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 16, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to New Orleans, LA · in-kind | $978 |
| Cvrx, Inc. Aug 12, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Atlanta, GA | $608 |
| Cvrx, Inc. Aug 12, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Norfolk, VA | $60.64 |
| Cvrx, Inc. Aug 12, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Minneapolis, MN | $34.00 |
| Bridgebio Pharma, Inc. Aug 7, 2025 | Travel and Lodging Attruby · Cardiomyopathy · travel to Norfolk, VA | $19.60 |
| Bridgebio Pharma, Inc. Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) Attruby · Cardiomyopathy | $2,790 |
| Bridgebio Pharma, Inc. Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) Attruby · Cardiomyopathy | $1,395 |
| Bayer HealthCare Pharmaceuticals Inc. Jul 9, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $22.11 |
| Kestra Medical Technology Services, Inc. Jul 3, 2025 | Consulting Fee Assure WCD · Cardiology/Vascular Diseases | $3,000 |
| Bayer HealthCare Pharmaceuticals Inc. Jul 2, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Whippany, NJ · in-kind | $465 |
| Cvrx, Inc. Jul 1, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Dallas, TX | $293 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $1,131 |
| AstraZeneca Pharmaceuticals LP Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) LOKELMA · Cardiovascular and Metabolism Company’s descriptionSpeaker Fee | $2,150 |
| AstraZeneca Pharmaceuticals LP Jun 19, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA Company’s descriptionConsulting Expenses | $90.72 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $447 |
| AstraZeneca Pharmaceuticals LP Jun 17, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Virginia Beach, VA · in-kind Company’s descriptionSpeaker Expenses | $18.69 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 16, 2025 | Consulting Fee Kerendia · Cardio-Renal | $7,592 |
| Cvrx, Inc. Jun 16, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $505 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 16, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Norfolk, VA · in-kind | $43.36 |
| Cvrx, Inc. Jun 16, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $34.00 |
| Kestra Medical Technology Services, Inc. Jun 13, 2025 | Consulting Fee Assure WCD · Cardiology/Vascular Diseases | $18,000 |
| AstraZeneca Pharmaceuticals LP Jun 10, 2025 | Consulting Fee LOKELMA · Cardiovascular and Metabolism | $2,954 |
| AstraZeneca Pharmaceuticals LP Jun 4, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA · in-kind Company’s descriptionConsulting Expenses | $464 |
| AstraZeneca Pharmaceuticals LP Jun 4, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Boston, MA · in-kind Company’s descriptionConsulting Expenses | $428 |
| Nuwellis, Inc. May 30, 2025 | Compensation for services other than consulting (speaking, faculty) Aquadex Smartflow Console · Cardiology | $3,200 |
| Scpharmaceuticals Inc. May 2, 2025 | Honoraria FUROSCIX · Cardiology | $3,200 |
| Merck Sharp & Dohme LLC Apr 21, 2025 | Consulting Fee | $896 |
| Scpharmaceuticals Inc. Mar 7, 2025 | Honoraria FUROSCIX · Cardiology | $4,800 |
| Scpharmaceuticals Inc. Jan 30, 2025 | Travel and Lodging FUROSCIX · Cardiology · travel to COLONIAL HEIGHTS, VA | $669 |
| Scpharmaceuticals Inc. Jan 30, 2025 | Travel and Lodging FUROSCIX · Cardiology · travel to COLONIAL HEIGHTS, VA | $60.00 |
| Nuwellis, Inc. Jan 15, 2025 | Education Aquadex Smartflow Console · Cardiology | $138 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 2 companies. The companies reported $83,533 in research payments for these studies, mostly to the institutions running them.
- Confirmation Study #22563
Bayer HealthCare Pharmaceuticals Inc. - A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left v…
Bayer HealthCare Pharmaceuticals Inc. - Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
Nuwellis, Inc. · Terminated · NCT05318105 - REDEFINE-HF Study #22438
Bayer HealthCare Pharmaceuticals Inc. - BAY 948862, A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV…
Bayer HealthCare Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.